Reduced regional cerebral blood flow in patients with heart failure

Bhaswati Roy1, Mary A Woo1, Danny J J Wang2

  • 1School of Nursing, University of California Los Angeles (UCLA), Los Angeles, CA, USA.

Insights

Heart failure patients exhibit reduced cerebral blood flow (CBF), particularly in brain regions affecting autonomic, mood, and cognitive functions. This lateralized reduction in CBF likely contributes to neural injury and associated deficits in heart failure.

Area of Science:

  • Neuroscience
  • Cardiology
  • Medical Imaging

Background:

  • Heart failure (HF) is associated with neural injury, autonomic, mood, and cognitive deficits.
  • These deficits may stem from altered cerebral blood flow (CBF) due to impaired cardiac output.
  • The precise distribution of regional CBF changes in HF patients remains unclear.

Purpose of the Study:

  • To compare regional CBF in HF patients versus control subjects.
  • To investigate the distribution of CBF changes using pseudo-continuous arterial spin labelling (ASL).

Main Methods:

  • Collected pseudo-continuous ASL data from 19 HF patients and 29 controls using 3.0-Tesla MRI.
  • Calculated, normalized, and smoothed whole-brain CBF maps.
  • Compared CBF between groups using ANCOVA, controlling for age, gender, and gray matter volume.

Main Results:

  • HF patients demonstrated significantly reduced CBF compared to controls.
  • The reduction in CBF was largely lateralized, affecting temporal, parietal, and occipital regions.
  • Specific areas with decreased CBF included the cortex, thalamus, cerebellum, and hippocampus.

Conclusions:

  • Heart failure patients exhibit reduced and lateralized CBF in key regulatory brain areas.
  • This diminished CBF is a likely contributor to lateralized brain injury.
  • The findings suggest a link between reduced CBF and the autonomic and neuropsychological deficits observed in HF.
Abstract

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
428
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
721
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.0K